Du Pont E I De Nemours & Co: (NYSE: DD)

$55.46

-0.11 (-0.20%)

Volume 4,415,254

May 23 02:31 PM ET

Zacks Rank: 3-Hold

 
 
#3
 
 

Full Company Report

Get Full Company Report for:

E.I. DuPont de Nemours is involved in science and technology in a range of disciplines including high-performance materials, specialty chemicals, pharmaceuticals and biotechnology. The company operates globally through strategic business units. Within the strategic business units, businesses manufacture and sell a wide range of products to many different markets, including the transportation, textile, construction, automotive, agricultural and hybrid seeds, nutrition and health, pharmaceuticals, packaging and electronics markets.

General Information

DU PONT (EI) DE
1007 MARKET ST
WILMINGTON, DE 19898
Phone: 3027741000
Fax: 302-774-7321
Web: http://www.dupont.com
Email: NA

Industry CHEM-DIVERSIFD
Sector Basic Materials
Fiscal Year End December
Last Reported Quarter 03/31/2013
Next EPS Date 07/23/2013

Price and Volume Information

Zacks Rank
Yesterday's Close 55.57
52 Week High 56.78
52 Week Low 41.67
Beta 1.52
20 Day Moving Average 7,591,955.00
Target Price Consensus 53.04

% Price Change

4 Week 5.35
12 Week 16.97
YTD 25.35

Share Information

Shares Outstanding (millions) 919.07
Market Capitalization (millions) 51,072.83
Short Ratio 5.52
Last Split Date 06/13/97

DD

% Price Change Relative to S&P 500

4 Week 0.47
12 Week 7.12
YTD 6.28

Dividend Information

Dividend Yield 3.24%
Annual Dividend $1.80
Payout Ratio 0.48
Change in Payout Ratio -0.10
Last Dividend Payout / Amount 05/13/2013 / $0.45

EPS Information

Current Quarter EPS Consensus Estimate 1.36
Current Year EPS Consensus Estimate 3.89
Estimated Long-Term EPS Growth Rate 8.40
Next EPS Report Date 07/23/2013

Consensus Recommendations

Current (1=Strong Buy, 5=Strong Sell) 2.39
30 Days Ago 2.39
60 Days Ago 2.39
90 Days Ago 2.39

Fundamental Ratios

P/E

Current FY Estimate 14.28
Trailing 12 Months 15.48
PEG Ratio 1.71

Price Ratios

Price/Book 4.23
Price/Cash Flow 10.66
Price / Sales 1.39

Current Ratio

03-31-13 1.95
12-31-12 1.56
09-30-12 1.58

Net Margin

03-31-13 12.67
12-31-12 7.45
09-30-12 7.89

Inventory Turnover

03-31-13 3.82
12-31-12 3.82
09-30-12 3.74

EPS Growth

vs. Previous Year -3.11%
vs. Previous Quarter 1,318.18%
   

ROE

03-31-13 31.50
12-31-12 33.55
09-30-12 36.65

Quick Ratio

03-31-13 1.34
12-31-12 1.02
09-30-12 1.10

Pre-Tax Margin

03-31-13 8.42
12-31-12 8.82
09-30-12 8.55

Debt-to-Equity

03-31-13 0.93
12-31-12 1.05
09-30-12 1.00

Sales Growth

vs. Previous Year -6.72%
vs. Previous Quarter 38.67%
   

ROA

03-31-13 6.73
12-31-12 6.86
09-30-12 7.34

Operating Margin

03-31-13 9.21
12-31-12 9.19
09-30-12 9.46

Book Value

03-31-13 13.14
12-31-12 10.66
09-30-12 11.26

Debt to Capital

03-31-13 47.81
12-31-12 50.69
09-30-12 49.51

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.